Yayınlar & Eserler

Yayın Ağı
Makaleler 22
Tümü (22)
SCI-E, SSCI, AHCI (19)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (1)
Scopus (22)
TRDizin (4)

1. Compatibility of different PET/CT criteria in evaluating treatment response and survival in non-small cell lung cancer patients treated with immunotherapy

EROĞLU İ., AYDOS U., ÜNLÜER ATEŞ Y., KÜÇÜKALİ S. B., AKDOĞAN O., ÜNER A., et al.
CLINICAL & TRANSLATIONAL ONCOLOGY , cilt.28, sa.8, ss.3103-3112, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study

Buyukaksoy M., Akturk Esen S., Turhan N., Sahiner E. S., EROĞLU İ., SERT A., et al.
Journal of Clinical Medicine , cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)

3. Endocrine-driven inflammatory-epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis

Grujic M., Zivkovic Radojevic M., Alaverdashvili T., EROĞLU İ., Krasic K., Jankovic K., et al.
FRONTIERS IN ENDOCRINOLOGY , cilt.17, 2026 (SCI-Expanded, Scopus) Creative Commons License

4. Ovarian Metastasis from EBV-Associated Undifferentiated Nasopharyngeal Carcinoma: An Exceptionally Rare Occurrence

Avsar H., EROĞLU İ., DEMİRCİ A., IŞIK GÖNÜL İ., ÜNER A.
ANTICANCER RESEARCH , cilt.46, sa.5, ss.2937-2943, 2026 (SCI-Expanded, Scopus)

5. Incidence and Patterns of Second Primary Malignancies in Genitourinary Cancer Survivors: A 20-Year Single-Center Experience

Eroglu I., Avsar H., sutcuoglu o., tahtaci g., Gürler F., Coskun U., et al.
Journal of oncological sciences , cilt.12, sa.1, ss.41-50, 2026 (Scopus, TRDizin) Creative Commons License

6. Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors

Gurbuz M., Tural D., Cil T., DEMİR H., KÖSTEK O., Sever O. N., et al.
JCO GLOBAL ONCOLOGY , cilt.12, 2026 (ESCI, Scopus) Sürdürülebilir Kalkınma

7. Clinicopathological Characteristics of Metastatic Colorectal Cancer Patients with Prolonged Survival

EROĞLU İ., SÜTCÜOĞLU O., SAVAŞ G., GÜRLER F., COŞKUN U., ÜNER A., et al.
Journal of oncological sciences , cilt.11, ss.244-252, 2025 (Scopus, TRDizin)

8. Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience

BAŞ O., İnci B. K., EROĞLU İ., Efil S. C., Kaya S., KUBİLAY TOLUNAY P., et al.
BMC Cancer , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

9. Efficacy and safety of neoadjuvant FLOT treatment for resectable gastric/gastroesophageal junction adenocarcinoma in Turkish and German patients; a real-world data

Eroğlu İ., Möhring C., Sadeghlar F., Mańczak A., Yazıcı O., Özet A., et al.
BMC CANCER , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

10. Induction chemotherapy followed by definitive chemoradiation in patients with inoperable esophageal squamous cell carcinoma: a multicenter retrospective study

Sahin T. K., Eroglu İ., Dilli I., Sutcuoglu O., Chalabiyev E., Guven D. C., et al.
DISCOVER ONCOLOGY , cilt.16, sa.1, 2025 (SCI-Expanded, Scopus)

11. Carcinoma erysipeloides, a case-report and review of the sixty-nine cases in the literature

EROĞLU İ., ÜNER A., GÜRLER F., YAZICI O., ÖZET A., ÖZDEMİR N.
American Journal of the Medical Sciences , cilt.369, sa.4, ss.485-490, 2025 (SCI-Expanded, Scopus)

12. Muscle function, exercise capacity, physical activity level and cardiovascular disease risk factor knowledge in patients with prolactinoma

Erkoc A., EROĞLU İ., Erbas T., Kutukcu E. C.
ENDOCRINE , cilt.85, sa.3, ss.1337-1345, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Utility of Noninvasive Scores in Patients With Acromegaly

Eroğlu İ., Iremli B. G., İdilman İ. S., Yuce D., Lay İ., Akata D., et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.109, 2023 (SCI-Expanded, Scopus)

14. Osteosarcopenia in acromegaly: reduced muscle quality and increased vertebral fat deposition

EROĞLU İ., Iremli B. G., Erkoc A., İDİLMAN İ. S., Yuce D., Calik-Kutukcu E., et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.46, ss.2573-2582, 2023 (SCI-Expanded, Scopus)

15. Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

Guven D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.8, ss.1807-1811, 2022 (SCI-Expanded, Scopus)

16. Potential role of tryptophan catabolism in cancer-related cognitive impairment

EROĞLU İ., Eroglu B. C.
NUTRITION , cilt.103-104, 2022 (SCI-Expanded, Scopus)

17. Extremely high erythrocyte sedimentation rate revisited in rheumatic diseases: a single-center experience

Ozsoy Z., BİLGİN E., Aksun M. S., EROĞLU İ., KALYONCU U.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.6, ss.1889-1899, 2022 (SCI-Expanded, Scopus, TRDizin)

18. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19)

EROĞLU İ., Eroglu B. C., Guven G. S.
NUTRITION , cilt.90, 2021 (SCI-Expanded, Scopus)

19. Extremely Elevated Erythrocyte Sedimentation Rate Revisited in Rheumatic Diseases: Flare-Up or Infection? Single Centre Retrospective Analysis

BİLGİN E., Ozsoy Z., Aksun M. S., EROĞLU İ., KALYONCU U.
ARTHRITIS & RHEUMATOLOGY , ss.2273-2275, 2021 (SCI-Expanded, Scopus)

20. SerumMonocyte-Chemoattractant Protein-1 CouldBean Indicator of CoronaryArtery Calcium Score

EROĞLU İ., Eroglu B. C.
JAMA CARDIOLOGY , cilt.6, sa.5, ss.604-605, 2021 (SCI-Expanded, Scopus)

21. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study

UYAROĞLU O. A., Basaran N. C., ÖZIŞIK L., TELLİ DİZMAN G., EROĞLU İ., Sahin T. K., et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE , cilt.33, sa.1, 2021 (SCI-Expanded, SSCI, Scopus)

22. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?

EROĞLU İ., Eroglu B. C., UYAROĞLU O. A., Guven G. S.
ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.24, sa.1, ss.19-20, 2020 (SCI-Expanded, Scopus, TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Impact of radiologically identified embryological origin on recurrence patterns and survival in resectable pancreatic head adenocarcinoma.

EROĞLU İ., Oruc A., Yesilyurt B., TOSUN S. N., Soylu Kocoglu S., Ugur Tuzcu T., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2026, cilt.44, (Özet Bildiri)

2. Prognostic significance and healthcare resource utilization of emergency department visit etiology in patients with prostate cancer.

Eken Y., EROĞLU İ., Soylu Kocoglu S., Savas G., Gurler F., Yazici O., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2026, cilt.44, (Özet Bildiri)

3. Clinical outcomes of adjuvant treatment strategies in locally advanced gastroesophageal and gastric adenocarcinoma with poor pathological response to neoadjuvant FLOT: A Turkish Oncology Group (TOG) study.

Ciftci A., Kutlu O., Canaslan K., EROĞLU İ., Yildizhan S., Bayram S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2026, cilt.44, (Özet Bildiri)

4. Bone marrow metastasis in prostate cancer: Treatment feasibility and survival in a real-world cohort.

EROĞLU İ., Celebi A., Usta S., Kilictas B., ÇOBAN E., Savas G., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2026, cilt.44, (Özet Bildiri)

5. Survivorship-focused content at the American Society of Clinical Oncology (ASCO) 2022-2024 annual meetings.

Rynar L., Naaman S., Bates B., Castiel M., Peterson D. E., Vos J., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2026, cilt.44, (Özet Bildiri)
Metrikler

Yayın

33

Yayın (WoS)

25

Yayın (Scopus)

23

Atıf (WoS)

126

H-İndeks (WoS)

5

Atıf (Scopus)

145

H-İndeks (Scopus)

6

Proje

1

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER